NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 12; no. 7; pp. P432 - P433
Main Authors McKinzie, David L, May, Patrick C, Boggs, Leonard N, Yang, Zhixiang, Brier, Richard A, Monk, Scott A, Willis, Brian A, Borders, Anthony R, Winneroski, Leonard L, Green, Steven J, Mergott, Dustin J
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.07.2016
Subjects
Neurology
Online AccessGet full text

Cover

Author Yang, Zhixiang
McKinzie, David L
Boggs, Leonard N
Brier, Richard A
Green, Steven J
May, Patrick C
Willis, Brian A
Monk, Scott A
Mergott, Dustin J
Winneroski, Leonard L
Borders, Anthony R
Author_xml – sequence: 1
  fullname: McKinzie, David L
– sequence: 2
  fullname: May, Patrick C
– sequence: 3
  fullname: Boggs, Leonard N
– sequence: 4
  fullname: Yang, Zhixiang
– sequence: 5
  fullname: Brier, Richard A
– sequence: 6
  fullname: Monk, Scott A
– sequence: 7
  fullname: Willis, Brian A
– sequence: 8
  fullname: Borders, Anthony R
– sequence: 9
  fullname: Winneroski, Leonard L
– sequence: 10
  fullname: Green, Steven J
– sequence: 11
  fullname: Mergott, Dustin J
BookMark eNpdkEFLw0AQhRepYFv9A57yBxJnNs3uFkRIl9QEYiI1gnpZNpsNJIYUGhX015to8eBhmPcO783wLcis3_eWkEsEDwHZVeu1uvvy6Kg9YJ6g4oTMMQioG1C-nv1pBmdkMQwtwAoEBnNyl-WZTJMskWHq3Mfh7i6UeZrf_ng5-lAW0S55CYskz5x86xRx5GxCGaGTZHGySYp856TPPgXKKDsnp7XuBntx3EvyuI0KGbvHRtciCOFWrA4Y17yGQBhewooi46uS8pLRQFfWX1Mtat9axktOmRUlao6GlpWufTPOklz_9trxyEdjD2owje2NrZqDNW-q2jcKQU1oVKsmNGpCo4CpEc0Yv_kXN13TN0Z3r_bTDu3-_dCP7ytUA1WgHiZ4EztkPqIPT_43_LRoYQ
ContentType Journal Article
Copyright 2016
Copyright_xml – notice: 2016
DOI 10.1016/j.jalz.2016.06.828
DeliveryMethod fulltext_linktorsrc
EISSN 1552-5279
EndPage P433
ExternalDocumentID S155252601631130X
1_s2_0_S155252601631130X
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1OC
1~.
1~5
24P
33P
4.4
457
4G.
53G
5VS
7-5
71M
7RV
7X7
8FI
8FJ
8P~
AACTN
AAEDT
AAHHS
AAIKJ
AAKOC
AALRI
AANLZ
AAOAW
AAXLA
AAXUO
AAYCA
ABBQC
ABCQJ
ABCUV
ABIVO
ABJNI
ABMAC
ABMZM
ABUWG
ABWVN
ACCFJ
ACCMX
ACCZN
ACGFS
ACGOF
ACPOU
ACRPL
ACXQS
ADBBV
ADBTR
ADEZE
ADHUB
ADKYN
ADMUD
ADNMO
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEIGN
AEKER
AENEX
AEQDE
AEUYR
AEVXI
AFKRA
AFTJW
AFWVQ
AGHFR
AGUBO
AGWIK
AGYEJ
AITUG
AIURR
AIWBW
AJBDE
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMFUW
AMRAJ
AMYDB
ANZVX
AZQEC
BENPR
BFHJK
BLXMC
C45
CCPQU
DCZOG
EBS
EJD
EMOBN
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYUFA
G-Q
GBLVA
HMCUK
HVGLF
HX~
HZ~
IHE
J1W
K9-
LATKE
LEEKS
M0R
M41
MO0
MOBAO
N9A
NAPCQ
O-L
O9-
OAUVE
OVD
OVEED
OZT
P-8
P-9
P2P
PC.
PGMZT
PIMPY
PSYQQ
Q38
QTD
RIG
ROL
RPM
RPZ
SDF
SDG
SEL
SES
SSZ
SUPJJ
T5K
TEORI
UKHRP
~G-
AAQFI
ABYKQ
AJBFU
EFLBG
LCYCR
WXSBR
ID FETCH-LOGICAL-e1088-d6f567a7f058c7b0421674b27b625ade392a8f3ee67b726e8b1a71c2bdaf3caf3
IEDL.DBID .~1
ISSN 1552-5260
IngestDate Fri Feb 23 02:23:21 EST 2024
Sun Feb 23 10:18:58 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-e1088-d6f567a7f058c7b0421674b27b625ade392a8f3ee67b726e8b1a71c2bdaf3caf3
ParticipantIDs elsevier_sciencedirect_doi_10_1016_j_jalz_2016_06_828
elsevier_clinicalkeyesjournals_1_s2_0_S155252601631130X
PublicationCentury 2000
PublicationDate July 2016
PublicationDateYYYYMMDD 2016-07-01
PublicationDate_xml – month: 07
  year: 2016
  text: July 2016
PublicationDecade 2010
PublicationTitle Alzheimer's & dementia
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
SSID ssj0040815
Score 2.1137621
SourceID elsevier
SourceType Publisher
StartPage P432
SubjectTerms Neurology
Title NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626
URI https://www.clinicalkey.es/playcontent/1-s2.0-S155252601631130X
https://dx.doi.org/10.1016/j.jalz.2016.06.828
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09T8MwELWqsrAgECDKR-WBNTRpYjsd05AqQW2KSosKi2UnjtQKFUTLwsBv5y5NKhAbQwZHcpScnXd31rt3hFwDwrmOl_lWkWtmeZoxq6d7uVX4THHtqtzReA45Snk88-7mbN4gYV0Lg7TKCvu3mF6idXWnU1mz87ZYdB5QPIyViliuA0g8xwp2T-Auv_na0Tw8cHms1ExlmHRxuyqc2XK8lurlE-ldHDU8fezIvvNIP7zM4JAcVOEhDbZvcEQaZnVMRuk4DYdJitIF9D4OJqMgrJsY0BDGQQhBafJcHjfR8YBO44j2gzByaJLGST-Zjid0-IQ9zCGxOCGzQTQNY6t6gmUcwAAr5wXjQonCZn4mNPxlWDmgu0JD7qJyAxGO8gvXGC606HLja0cJJ-vqXBVuBtcpaa5eV-aMUNswnQmIYFgGrjlTfo7dqVAFrHBV4akWEfX3y7oyE7DErKuNvZaOXHelLf8Yv0XYbuav9ZMAzbKmki0lWlyixaXNJVj8_J_zLsg-jrbE2UvS3Lx_mCsIDza6Xa5_m-yNH6Po9hvQtbKK
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV07T8MwELZKGWBBIECUpwcYQ_OynQ4MaWiV0DZFUKTCYuzEkVqhgmgRgoE_xR_knCYViA2JIUNiOZLP5-_urO_uEDoGhHMsN_GMLJXEcCUhRkM2UiPziKDSEakl9T1kL6bhjXsxJMMK-ixzYTStssD-OabnaF18qRfSrD-NRvVrXTyM5BWxHAuQeFgwKzvq7RXitulZdA6bfGLb7dYgCI2itYChLDhXRkozQplgmUm8hEnQXM3GlzaTEA-IVIHXILzMUYoyyWyqPGkJZiW2TEXmJPDAf5fQsgtwodsmnH4seCUu2FiSF2klOsqjZpGpMyeVjcXDu-aTUV001NMt4Bcm8JtZa6-jtcIfxf58yRuooiabqBf346AbxXop-DL0r3p-UHZNwAG8-wF4wdFdfr-F-208CFu46QctC0dxGDWjQf8Kd29103SIZLbQzb8IZxtVJ48TtYOwqYhMGLhMJAFfIBFeqtth6bJjmSMyV9QQK9fPy1RQAC81LU7SlFt8anOT_9rtGiKLmT8UhoMt4CV3bcy1xLmWODcpB4nv_nHeEVoJB70uB-F39tCqHpmzdvdRdfb8og7AN5nJw1wXMLr_b-X7Al817o4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NONCLINICAL+PHARMACOLOGICAL+CHARACTERIZATION+OF+THE+BACE1+INHIBITOR+LY3202626&rft.jtitle=Alzheimer%27s+%26+dementia&rft.au=McKinzie%2C+David+L&rft.au=May%2C+Patrick+C&rft.au=Boggs%2C+Leonard+N&rft.au=Yang%2C+Zhixiang&rft.date=2016-07-01&rft.issn=1552-5260&rft.volume=12&rft.issue=7&rft.spage=P432&rft.epage=P433&rft_id=info:doi/10.1016%2Fj.jalz.2016.06.828&rft.externalDBID=ECK1-s2.0-S155252601631130X&rft.externalDocID=1_s2_0_S155252601631130X
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15525260%2FS1552526016X00131%2Fcov150h.gif